Table of Contents
Table of Contents
Preface
List of Contributors
Acknowledgements
Chapter 1. Type I Interferon Signalling Pathway and its Regulation
(Xiaobing Luo, Yihong Yao and Nan Shen, Translational Sciences, MedImmune, LLC, Gaithersburg, MD, USA, and others)
<a href=”https://novapublishers.com/wp-content/uploads/2019/08/978-1-62417-379-0_ch1.pdf” target=”_blank” rel=”noopener”>Free Download Available</a>
Chapter 2. Type I Interferons and Autoimmunity
(Jeremy Di Domizio and Wei Cao, Department of Immunology,
The University of Texas MD Anderson Cancer Center, Houston, TX, USA)
Chapter 3. Type I Interferons in Systemic Lupus Erythematosus
(Gary P. Sims, Daniel C. Rowe, Bo Chen and Ronald Herbst, Respiratory, Inflammation and Autoimmunity, MedImmune, LLC, Gaithersburg, MD, USA)
<a href=”https://novapublishers.com/wp-content/uploads/2019/08/978-1-62417-379-0_ch3.pdf” target=”_blank” rel=”noopener”>Free Download Available</a>
Chapter 4. Type I Interferons in Sjögren’s Syndrome
(Zheng Liu, Bahija Jallal, Lars Rönnblom and Yihong Yao, Translational Sciences, MedImmune, LLC, Gaithersburg, MD, USA, and others)
Chapter 5. Type I Interferons in Systemic Sclerosis
(Robert Lafyatis, Zheng Liu and Yihong Yao, Boston University School of Medicine, Boston, MA, USA, and others)
Chapter 6. The Type I Interferon System in Rheumatoid Arthritis
(Cornelis L. Verweij and Saskia Vosslamber, VU University Medical Center, Amsterdam, The Netherlands)
Chapter 7. Type I Interferons in Psoriasis
(Zheng Liu, Wei Cao, James G. Kruger and Koustubh Ranade, Translational Sciences, MedImmune, LLC, Gaithersburg, MD, USA, and others)
Chapter 8. Type I Interferons in Dermatomyositis and Polymyositis
(Steven A. Greenberg, Department of Neurology, Division of Neuromuscular Disease, Brigham and Women’s Hospital, and Children’s Hospital Informatics Program, Harvard Medical School, Boston, MA, USA)
Chapter 9. The Interferon System in MS: Towards a Personalized Medicine Approach for Interferon-β Therapy
(Cornelis L. Verweij and Saskia Vosslamber, Department of Pathology, VU Medical Center, Amsterdam, The Netherlands)
Chapter 10. Developing Anti-Type I Interferon Therapy in Autoimmune Diseases and Personalized Medicine
(Brandon W. Higgs, Bahija Jallal and Yihong Yao, Translational Sciences, MedImmune, LLC, Gaithersburg, MD, USA)
Index
Reviews
“This is an important and timely resource of type I interferons and their relationship to autoimmune disease. The book fist addresses the basic biology of interferon signaling and gives the reader a firm grasp of the molecular machinery operating both upstream and downstream of the interferons.” <a href=”https://novapublishers.com/wp-content/uploads/2019/08/Book-Review-Type-I-Interferon-in-Autoimmune-Diseases-and-its-Clinical-Applications.docx” target=”_blank” rel=”noopener”>READ MORE…</a> – <strong>Dr. David Fiorentino, an Associate Professor of Dermatology at Stanford University School of Medicine</strong>